Text-mining-based feature selection for anticancer drug response prediction
Grace Wu1, Arvin Zaker2,3, Amirhosein Ebrahimi2
1Division of Engineering Science, University of Toronto, Toronto, M5S2E4, Canada.
Bioinformatics Advances
|April 12, 2024
Summary
Text mining of scientific literature improves anticancer drug response prediction using machine learning. This approach outperforms traditional methods and successfully predicts responses in both in vitro and in vivo cancer models.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Predicting anticancer treatment response from genomic data is crucial for personalized medicine.
- Machine learning models are widely used for predicting drug response from gene expression data.
- Identifying relevant features (genes) from large datasets is a significant challenge in model construction.
Purpose of the Study:
- To evaluate the efficacy of text-mining extracted features for machine learning models in predicting anticancer drug response.
- To compare text-mining based feature selection with traditional methods.
- To assess the generalizability of models trained on in vitro data to in vivo cancer models.
Main Methods:
- Utilized genes extracted via text-mining of scientific literature as features.
- Applied machine learning models to two independent cancer pharmacogenomic datasets.
- Compared performance against traditional feature selection techniques.
Main Results:
- Text-mining-based features significantly outperformed traditional feature selection methods.
- Machine learning models utilizing text-mining features demonstrated strong predictive performance.
- Models trained on in vitro data successfully predicted responses in in vivo cancer models.
Conclusions:
- Text-mining offers an effective and easily implementable approach for feature selection in machine learning for anticancer drug response prediction.
- This method enhances the development of personalized medicine strategies.
- The approach shows promise for bridging in vitro and in vivo predictive modeling.
Related Concept Videos
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


